Is AOD-9604 the same as HGH?
No. It is a fragment modeled on part of the GH molecule, studied for metabolic effects rather than as full GH replacement.
EDUCATION CENTER
AOD-9604 Guide
A patient-friendly education resource for clinician-guided AOD-9604 peptide therapy.
What is AOD-9604?
AOD-9604 is a synthetic peptide fragment modeled on the C-terminal region of human growth hormone (often described as GH fragment 177–191). Early metabolic studies explored lipolytic activity without the full growth-promoting profile of intact GH.
It is not FDA-approved for weight loss. It is not a GLP-1. At Vita Bella, AOD-9604 is prescribed only after licensed provider review of body-composition goals, labs, and whether a better-evidenced option exists.
How it may work
Research on this GH fragment focused on fat-metabolism pathways in animals and limited human safety/tolerability work. That is a different story from tesamorelin’s visceral-fat trials or semaglutide’s obesity outcome trials.
AOD-9604 is not a substitute for calorie quality, protein intake, or resistance training, and it does not replace evaluation of thyroid, sleep, or GLP-1 candidacy.
Potential uses
Clinicians may discuss AOD-9604 for body-composition support when a GH-fragment peptide is being considered as part of a supervised plan.
Stubborn fat is often a nutrition, sleep, hormone, or medication issue. A fragment peptide will not diagnose those.
Candidate assessment
Candidates are typically adults with clinician-guided body-composition goals who understand the limited human evidence.
Pregnancy, active eating-disorder care, or uncontrolled endocrine disease may exclude therapy.
Labs & evaluation
Weight-history, glucose/HbA1c, and current medications (especially GLP-1s) inform whether AOD-9604 adds anything.
Your provider may compare it with tesamorelin, MOTS-c, metformin, or a GLP-1 — different tools, different evidence.
Forms & dosing
AOD-9604 is typically discussed as a subcutaneous injectable with individualized reconstitution and schedule.
Do not copy a research-chemical “fat-loss peptide” calendar onto a compounded vial.
Injection guidance
Use sterile technique, rotate abdominal or other approved sites, and follow Vita Bella injection resources.
Store reconstituted peptide as directed. Discard according to pharmacy dating guidance.
Side effects
Possible effects include injection-site redness or headache. Human safety work is more limited than for approved obesity drugs.
Report unexpected hypoglycemia if you use other metabolic medications, or signs of allergic reaction.
Safety considerations
AOD-9604 is not intact growth hormone, but stacking it with other GH-axis agents still needs clinician oversight.
Quality compounding matters. Online “research AOD” is not a clinical weight-loss program.
FAQs
AOD-9604 vs tesamorelin for belly fat?
Tesamorelin has a clearer clinical trial history for visceral adipose tissue in a specific FDA-labeled setting. AOD-9604 does not match that evidence bar. Your clinician will not treat them as twins.
Can I use AOD-9604 with semaglutide or tirzepatide?
Only if one clinician owns the whole plan. Adding a fragment peptide does not automatically prevent GLP-1 muscle loss.
References
Related guides
Ready to talk with a Vita Bella provider?
Start with a Vita Bella membership consultation so a licensed provider can review goals and whether AOD-9604, tesamorelin, a GLP-1, or nutrition-first care is the better fit.